Literature DB >> 8127943

Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma.

R M Szeimies1, T Sassy, M Landthaler.   

Abstract

Penetration potency of delta-aminolevulinic acid (ALA) was studied by examining fluorescence of endogenous protoporphyrin IX in different histological types of basal cell carcinoma. Ten basal cell carcinomas were coated with an ointment containing 10% ALA prior to excision; five served as controls. Tumors were excised either 4 h or 12 h after application of ALA using a modified Mohs' micrographic surgical technique. Horizontal sections were cut from deep dermis to tumor surface and examined under a fluorescence microscope. After 4 h of application, only skin appendages demonstrated fluorescence typical of protoporphyrin IX. After 12 h, fluorescence was detectable in tumor cells in deep dermis. The five controls revealed no fluorescence at any site. These results may confirm the high penetration potential of topically applied ALA and its usefulness in photodynamic therapy. For tumors penetrating to deep dermis, an application time of more than 4 h seems necessary, at least when hydrophilic solvents for ALA are used.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8127943     DOI: 10.1111/j.1751-1097.1994.tb05003.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  11 in total

1.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

Review 2.  Beyond the margins: real-time detection of cancer using targeted fluorophores.

Authors:  Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

3.  Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism.

Authors:  C Fritsch; B Verwohlt; K Bolsen; T Ruzicka; G Goerz
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

4.  Autoradiographic and scintillation analysis of 5-aminolevulinic acid permeation through epithelialised tissue: implications for topical photodynamic therapy of superficial gynaecological neoplasias.

Authors:  Paul A McCarron; Ryan F Donnelly; A David Woolfson
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

5.  Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.

Authors:  A Martin; W D Tope; J M Grevelink; J C Starr; J L Fewkes; T J Flotte; T F Deutsch; R R Anderson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 6.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

Review 7.  Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.

Authors:  C Fritsch; P Lehmann; W Stahl; K W Schulte; E Blohm; K Lang; H Sies; T Ruzicka
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo.

Authors:  P Babilas; V Schacht; G Liebsch; O S Wolfbeis; M Landthaler; R-M Szeimies; C Abels
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

9.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster.

Authors:  C Abels; P Heil; M Dellian; G E Kuhnle; R Baumgartner; A E Goetz
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.

Authors:  N van der Veen; H S de Bruijn; R J Berg; W M Star
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.